Dr. Matt Cahill appointed COO of Qu BiologicsBy Publishing TeamJanuary 24, 2023 BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) — Qu Biologics Inc.a clinical-stage biopharmaceutical company developing Site-Specific Immunomodulators (SSI), a…
Dr. Matt Cahill appointed COO of Qu BiologicsBy Publishing TeamJanuary 24, 2023 BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) — Qu Biologics Inc.a clinical-stage biopharmaceutical company developing Site-Specific Immunomodulators (SSI), a…